Hello my dears,
a short UPDATE.
In a correction, my growth portfolio often underperforms the comparable market.
This was also the case in November.
Perhaps I am not yet conservative enough here, especially when it comes to a bear market.
What do you think?
Because I have usually performed better than the comparable market in strong months.
I am still better than the market YTD.
The tops and flops are attached.
With the tops you can see that Pharma has run.
The reason at Googel should be known.
At Albemarle, the rise in lithium prices
With the flops
were the earnings at elf Beauty,
the AI correction at Innodata,
at AeroVironment a correction of the defense values (peace negotiations)
the capital increase at Kitron,
November performance
Tenbagger - 4.58 %
Core S & P 500 ETF $CSPX (+0,04 %) - 0,47 %
NASDAQ 100 ETF $CSNDX (+0,32 %) - 2,27 %
World ETF $IWDA (+0,34 %) - 0,36 %
YTD Performance
Tenbagger + 11.17 %
S & P 500 ETF $CSPX (+0,04 %) + 3,49 %
NASDAQ 100 ETF $CSNDX (+0,32 %) + 6,79 %
World ETF $IWDA (+0,34 %) + 5,87 %

